Rafael Cantón

51.1k total citations · 9 hit papers
759 papers, 30.4k citations indexed

About

Rafael Cantón is a scholar working on Molecular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rafael Cantón has authored 759 papers receiving a total of 30.4k indexed citations (citations by other indexed papers that have themselves been cited), including 330 papers in Molecular Medicine, 256 papers in Epidemiology and 248 papers in Infectious Diseases. Recurrent topics in Rafael Cantón's work include Antibiotic Resistance in Bacteria (330 papers), Antibiotics Pharmacokinetics and Efficacy (131 papers) and Bacterial Identification and Susceptibility Testing (123 papers). Rafael Cantón is often cited by papers focused on Antibiotic Resistance in Bacteria (330 papers), Antibiotics Pharmacokinetics and Efficacy (131 papers) and Bacterial Identification and Susceptibility Testing (123 papers). Rafael Cantón collaborates with scholars based in Spain, United States and United Kingdom. Rafael Cantón's co-authors include Fernando Baquero, Teresa M. Coque, José Luis Martínez, Javier Pemán, Patricia Ruíz-Garbajosa, Juan Carlos Galán, Luı́sa Peixe, Patrice Nordmann, Antonio Oliver and Ângela Novais and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Rafael Cantón

741 papers receiving 29.5k citations

Hit Papers

Antibiotics and antibiotic resistance in water environments 2006 2026 2012 2019 2008 2006 2006 2012 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibiotics and antibiotic resistance in water environments
    2008 1.6k citations Fernando Baquero, Rafael Cantón et al. profile →
  2. The CTX-M β-lactamase pandemic
    2006 927 citations Rafael Cantón, Teresa M. Coque profile →
  3. CTX-M: changing the face of ESBLs in Europe
    2006 739 citations Rafael Cantón, Teresa M. Coque et al. Journal of Antimicrobial Chemotherapy profile →
  4. CTX-M Enzymes: Origin and Diffusion
    2012 718 citations Rafael Cantón, Juan Carlos Galán et al. profile →
  5. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
    2012 680 citations Rafael Cantón et al. profile →
  6. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
    2008 663 citations Teresa M. Coque, Fernando Baquero et al. profile →
  7. Dissemination of Clonally RelatedEscherichia coliStrains Expressing Extended-Spectrum β-Lactamase CTX-M-15
    2008 591 citations Teresa M. Coque, Fernando Baquero et al. profile →
  8. EUCAST expert rules in antimicrobial susceptibility testing
    2011 502 citations Rafael Cantón et al. profile →
  9. Antimicrobial Resistance in the Global Health Network: Known Unknowns and Challenges for Efficient Responses in the 21st Century
    2023 108 citations Teresa M. Coque, Rafael Cantón et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Cantón Spain 81 15.7k 8.4k 7.0k 6.7k 5.6k 759 30.4k
Fernando Baquero Spain 87 12.5k 0.8× 5.6k 0.7× 5.9k 0.8× 4.4k 0.7× 7.8k 1.4× 493 29.4k
Yehuda Carmeli Israel 79 20.0k 1.3× 8.8k 1.0× 8.3k 1.2× 6.6k 1.0× 5.6k 1.0× 332 34.2k
Louis B. Rice United States 58 13.3k 0.8× 6.1k 0.7× 8.0k 1.1× 3.8k 0.6× 6.7k 1.2× 176 27.3k
Christian G. Giske Sweden 51 15.7k 1.0× 5.6k 0.7× 3.7k 0.5× 5.8k 0.9× 4.6k 0.8× 233 23.1k
David M. Livermore United Kingdom 96 23.7k 1.5× 6.5k 0.8× 4.3k 0.6× 8.3k 1.3× 7.1k 1.3× 405 31.9k
Gunnar Kahlmeter Sweden 54 10.7k 0.7× 6.3k 0.7× 4.4k 0.6× 3.5k 0.5× 4.0k 0.7× 204 21.4k
David C. Hooper United States 78 12.8k 0.8× 4.8k 0.6× 5.3k 0.8× 3.5k 0.5× 6.7k 1.2× 274 24.2k
Harald Seifert Germany 65 12.7k 0.8× 5.7k 0.7× 5.3k 0.8× 6.2k 0.9× 5.4k 1.0× 282 21.6k
Arjun Srinivasan United States 57 9.2k 0.6× 6.1k 0.7× 5.2k 0.7× 3.3k 0.5× 3.4k 0.6× 215 22.5k
Robert A. Bonomo United States 94 30.5k 1.9× 9.2k 1.1× 5.3k 0.8× 9.9k 1.5× 9.2k 1.6× 723 39.8k

Countries citing papers authored by Rafael Cantón

Since Specialization
Citations

This map shows the geographic impact of Rafael Cantón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Cantón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Cantón more than expected).

Fields of papers citing papers by Rafael Cantón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Cantón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Cantón. The network helps show where Rafael Cantón may publish in the future.

Co-authorship network of co-authors of Rafael Cantón

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Cantón. A scholar is included among the top collaborators of Rafael Cantón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Cantón. Rafael Cantón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández-García, Laura, Carla López-Causapé, Lucía Blasco, et al.. (2025). MGE- Acr Clusters in Pseudomonas aeruginosa Clinical Isolates. 6(1). 124–135.
2.
Candel, Francisco Javier, Miguel Salavert, Rafael Cantón, et al.. (2024). The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document. Critical Care. 28(1). 440–440. 7 indexed citations
3.
Caballero, Juan de Dios, et al.. (2024). Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis. European Journal of Clinical Microbiology & Infectious Diseases. 43(7). 1349–1353. 1 indexed citations
4.
Cantón, Rafael, Pilar Ramos, Alejandra García‐Botella, et al.. (2024). Human intestinal microbiome: Role in health and disease. Revista Española de Quimioterapia. 37(6). 438–453. 14 indexed citations
5.
Castillo-Polo, Juan Antonio, Marta Hernández-García, María Isabel Morosini, et al.. (2023). Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain. Journal of Antimicrobial Chemotherapy. 78(5). 1259–1264. 18 indexed citations
6.
Rodríguez‐Artalejo, Fernando, Julián Ruiz‐Galiana, Rafael Cantón, et al.. (2023). COVID -19: On the threshold of the fifth year. The situation in Spain. Revista Española de Quimioterapia. 37(1). 17–28. 2 indexed citations
7.
Moreno, Santiago, Fernando Rodríguez‐Artalejo, Julián Ruiz‐Galiana, et al.. (2023). Tuberculosis in Spain: An opinion paper. Revista Española de Quimioterapia. 36(6). 562–583. 1 indexed citations
8.
Larrosa, Nieves, Andrés Canut-Blasco, Natividad Benito, et al.. (2022). Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(7). 430–435. 1 indexed citations
9.
Larrosa, Nieves, Andrés Canut-Blasco, Natividad Benito, et al.. (2022). Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada. Enfermedades Infecciosas y Microbiología Clínica. 41(7). 430–435. 3 indexed citations
10.
Fernández-García, Laura, Lucía Blasco, Olga Pacios, et al.. (2022). Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2. Microbiology Spectrum. 10(5). e0239822–e0239822. 21 indexed citations
11.
Bermejo-Peláez, David, Lin Lin, Jesús Mateos‐Nozal, et al.. (2022). A Smartphone-Based Platform Assisted by Artificial Intelligence for Reading and Reporting Rapid Diagnostic Tests: Evaluation Study in SARS-CoV-2 Lateral Flow Immunoassays. JMIR Public Health and Surveillance. 8(12). e38533–e38533. 12 indexed citations
12.
Fluit, Ad C., Jumamurat R. Bayjanov, Barry Benaissa-Trouw, et al.. (2022). Whole-genome analysis of Haemophilus influenzae strains isolated from persons with cystic fibrosis. Journal of Medical Microbiology. 71(8). 1 indexed citations
13.
14.
Sempere, José M., Juan Carlos Galán, Andrés Moyá, et al.. (2021). Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing model. PubMed. 2. uqab011–uqab011. 4 indexed citations
15.
Rodríguez, Irene, Val F. Lanza, Javier Zamora, et al.. (2021). A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates. mSphere. 6(6). e0086821–e0086821. 25 indexed citations
16.
Caballero, Juan de Dios, Rosa Girón, Rosa del Campo, et al.. (2017). Antibiotic prescription patterns in Spanish cystic fibrosis patients: results from a national multicenter study.. SHILAP Revista de lepidopterología. 41(3). 391–400. 2 indexed citations
17.
Tenover, Fred C., Rafael Cantón, Fred Weir, et al.. (2013). Detection of Colonization by Carbapenemase-Producing Gram-Negative Bacilli in Patients by Use of the Xpert MDRO Assay. Journal of Clinical Microbiology. 51(11). 3780–3787. 67 indexed citations
18.
Gimeno, Concepción, et al.. (2010). [Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].. PubMed. 23(3). 144–52. 6 indexed citations
19.
Cantón, Rafael, Javier Pemán, M Gobernado, A Viudes, & Ana Espinel‐Ingroff. (2005). Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest Methods. Antimicrobial Agents and Chemotherapy. 49(4). 1593–1596. 51 indexed citations
20.
Cantón, Rafael, et al.. (2004). [Coverage of the 23-valent pneumococcal vaccine in those older than 64 years of age in the region of Castellon and Valencia, Spain].. PubMed. 17(2). 155–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Baquero Breakdown of academic impact, for papers by Yehuda Carmeli Breakdown of academic impact, for papers by Louis B. Rice Breakdown of academic impact, for papers by Christian G. Giske Breakdown of academic impact, for papers by David M. Livermore Breakdown of academic impact, for papers by Gunnar Kahlmeter Breakdown of academic impact, for papers by David C. Hooper Breakdown of academic impact, for papers by Harald Seifert Breakdown of academic impact, for papers by Arjun Srinivasan Breakdown of academic impact, for papers by Robert A. Bonomo
Rankless by CCL
2026